MicroRNA-1203 (miR-1203)

MicroRNA-1203 (miR-1203) is a small, endogenous, non-coding RNA molecule in humans classified as a microRNA. MicroRNAs are involved in the regulation of gene expression by binding to target messenger RNAs (mRNAs), primarily resulting in translational repression or mRNA degradation[1][5]. MicroRNAs broadly regulate cell development, apoptosis, proliferation, and differentiation, and have roles in the pathogenesis of multiple diseases, especially cancer[1][4][3]. However, there is no substantial evidence in the literature for any scientific or disease-specific significance, biological function, or therapeutic targeting of miR-1203 or hsa-mir-1203. No references were found linking miR-1203 to clinical biomarkers, therapeutic interventions, or drug interactions. Rationale: - MicroRNA-1203 fits the definition of a microRNA but there is insufficient public evidence linking this specific miRNA to a defined biological function, disease, therapeutic role, or clinical utility. - None of the sources provided mention miR-1203 specifically, and global miRNA review literature[1][3][4][5] or regulatory pathways do not reference miR-1203 in any capacity. - miR-1203 appears in microRNA databases (such as miRBase and NCBI Gene), but with minimal annotation and no functional or disease associations. - Therefore, it is not considered a validated therapeutic target, and the record is problematic due to missing or insufficient information about this entity.

Other names

hsa-mir-1203MIR1203MIRN1203